Search Results 591-600 of 16285 for Efficacy

  1. 53-Week Study Evaluating The Safety And Efficacy Of Intra-Articular Injections Of TPX-100 With Mild To Severe Tibio-Femoral Osteoarthritis Of The Knee - Mayo Clinic

    53-Week Study Evaluating The Safety And Efficacy Of Intra-Articular Injections Of TPX-100 With Mild To Severe Tibio-Femoral Osteoarthritis Of The Knee. Print ...

  2. Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease - Mayo Clinic

    Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease · Overview · Participation eligibility.

  3. Phase 2 Safety And Efficacy Study Of Tulisokibart (MK-7240/PRA023) In Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) - Mayo Clinic

    Phase 2 Safety And Efficacy Study Of Tulisokibart (MK-7240/PRA023) In Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) ...

  4. A Study To Investigate Efficacy & Safety Of Intratumoral INT230-6 Compared To US Standard Of Care In Adults With Soft Tissue Sarcomas (INVINCIBLE-3) - Mayo Clinic

    A Study To Investigate Efficacy & Safety Of Intratumoral INT230-6 Compared To US Standard Of Care In Adults With Soft Tissue Sarcomas (INVINCIBLE-3). Print ...

  5. A Study To Investigate The Safety And Efficacy Of KQB365 As Monotherapy And In Combination In Participants With Advanced Solid Malignancies - Mayo Clinic

    Clinical Trials · A Study To Investigate The Safety And Efficacy Of KQB365 As Monotherapy And In Combination In Participants With Advanced Solid Malignancies.

  6. A Study To Evaluate The Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderate To Severe Crohn's Disease (MK-7240-008) - Mayo Clinic

    The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease.

  7. Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney ...

  8. A Study To Evaluate The Adverse Events, And Efficacy Of Intravenous (IV) Of Telisotuzumab Adizutecan In Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab In Adult Participants With Metastatic Colorectal Cancer - Mayo Clinic

    A Study To Evaluate The Adverse Events, And Efficacy Of Intravenous (IV) Of Telisotuzumab Adizutecan In Combination With IV Oxaliplatin, Fluorouracil, Folinic ...

  9. Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis - Mayo Clinic

    The purpose of this study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to a daily oral dose of ...

  10. Examining the efficacy and safety of CBD in patients with idiopathic and diabetic gastroparesis - Mayo Clinic

    Individuals with gastroparesis experience a variety of upper gastrointestinal symptoms, including nausea, bloating, abdominal pain, vomiting, early satiety ...